BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23795938)

  • 1. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer J; Rosenfeld M
    Clin Microbiol Infect; 2013 Nov; 19(11):E483-9. PubMed ID: 23795938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young US children with cystic fibrosis.
    Psoter KJ; Rosenfeld M; De Roos AJ; Mayer JD; Wakefield J
    Am J Epidemiol; 2014 Jun; 179(12):1503-13. PubMed ID: 24875373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis.
    Psoter KJ; De Roos AJ; Mayer JD; Kaufman JD; Wakefield J; Rosenfeld M
    Ann Am Thorac Soc; 2015 Mar; 12(3):385-91. PubMed ID: 25594356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographical differences in first acquisition of Pseudomonas aeruginosa in cystic fibrosis.
    Ranganathan SC; Skoric B; Ramsay KA; Carzino R; Gibson AM; Hart E; Harrison J; Bell SC; Kidd TJ;
    Ann Am Thorac Soc; 2013 Apr; 10(2):108-14. PubMed ID: 23607838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis.
    Psoter KJ; DE Roos AJ; Wakefield J; Mayer JD; Bryan M; Rosenfeld M
    Epidemiol Infect; 2016 Apr; 144(5):1075-83. PubMed ID: 26449886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus.
    Buchs C; Dalphin ML; Sanchez S; Perceval M; Coutier L; Mainguy C; Kassaï-Koupaï B; Reix P
    Eur J Pediatr; 2017 Jul; 176(7):891-897. PubMed ID: 28508992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis.
    Mainz JG; Naehrlich L; Schien M; Käding M; Schiller I; Mayr S; Schneider G; Wiedemann B; Wiehlmann L; Cramer N; Pfister W; Kahl BC; Beck JF; Tümmler B
    Thorax; 2009 Jun; 64(6):535-40. PubMed ID: 19282318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.
    Heltshe SL; Mayer-Hamblett N; Burns JL; Khan U; Baines A; Ramsey BW; Rowe SM;
    Clin Infect Dis; 2015 Mar; 60(5):703-12. PubMed ID: 25425629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.
    Hubert D; Réglier-Poupet H; Sermet-Gaudelus I; Ferroni A; Le Bourgeois M; Burgel PR; Serreau R; Dusser D; Poyart C; Coste J
    J Cyst Fibros; 2013 Sep; 12(5):497-503. PubMed ID: 23291443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
    Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Respiratory Bacterial Detection and Antistaphylococcal Antibiotic Prophylaxis in Young Children with Cystic Fibrosis.
    Hurley MN; Fogarty A; McKeever TM; Goss CH; Rosenfeld M; Smyth AR
    Ann Am Thorac Soc; 2018 Jan; 15(1):42-48. PubMed ID: 29035090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.
    Emerson J; Rosenfeld M; McNamara S; Ramsey B; Gibson RL
    Pediatr Pulmonol; 2002 Aug; 34(2):91-100. PubMed ID: 12112774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors for multiple antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis.
    Merlo CA; Boyle MP; Diener-West M; Marshall BC; Goss CH; Lechtzin N
    Chest; 2007 Aug; 132(2):562-8. PubMed ID: 17646236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
    Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
    Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis.
    Kosorok MR; Jalaluddin M; Farrell PM; Shen G; Colby CE; Laxova A; Rock MJ; Splaingard M
    Pediatr Pulmonol; 1998 Aug; 26(2):81-8. PubMed ID: 9727757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.
    Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC
    Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
    Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
    JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.
    Nixon GM; Armstrong DS; Carzino R; Carlin JB; Olinsky A; Robertson CF; Grimwood K
    J Pediatr; 2001 May; 138(5):699-704. PubMed ID: 11343046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.